Aurinia Pharmaceuticals
AUPH
#4711
Rank
NZ$3.58 B
Marketcap
NZ$27.56
Share price
-1.71%
Change (1 day)
102.80%
Change (1 year)

Earnings for Aurinia Pharmaceuticals (AUPH)

Earnings in 2025 (TTM): NZ$0.20 Billion

According to Aurinia Pharmaceuticals 's latest financial reports the company's current earnings are NZ$0.28 Billion. , an increase over its 2024 earnings that were of NZ$20.97 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Aurinia Pharmaceuticals from 1999 to 2025

Annual earnings

Year Earnings Change
2025 NZ$0.20 B864.64%
2024 NZ$20.97 M-116.44%
2023 -NZ$0.13 Billion-31.8%
2022 -NZ$0.19 Billion-39.4%
2021 -NZ$0.31 Billion61.9%
2020 -NZ$0.2 Billion-9.73%
2019 -NZ$0.22 Billion92.65%
2018 -NZ$0.11 Billion36.39%
2017 -NZ$80.37 Million106.29%
2016 -NZ$38.96 Million-15.4%
2015 -NZ$46.05 Million65.84%
2014 -NZ$27.77 Million129.82%
2013 -NZ$12.09 Million-26.6%
2012 -NZ$16.47 Million
2010 -NZ$9.32 Million-39.22%
2009 -NZ$15.34 Million-43.78%
2008 -NZ$27.28 Million-53.19%
2007 -NZ$58.28 Million42.97%
2006 -NZ$40.76 Million-23.03%
2005 -NZ$52.96 Million36.1%
2004 -NZ$38.92 Million172.57%
2003 -NZ$14.28 Million484.61%
2002 -NZ$2.45 Million
2000 -NZ$11.6 Million453.81%
1999 -NZ$2.1 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Regeneron Pharmaceuticals
REGN
NZ$8.93 B 4,314.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Pieris Pharmaceuticals
PIRS
-NZ$37.78 Million-118.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Aeterna Zentaris
AEZS
-NZ$9.37 Million-104.63%๐Ÿ‡บ๐Ÿ‡ธ USA